MedTrace Logo

Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)

NCT03296592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2026-03-17

No results posted yet for this study

Summary

Patients who have been diagnosed with Cervical Spondylotic Myelopathy will be asked to undergo an MRI using diffusion basis spectrum imaging (DBSI) technology. The patients will have this MRI preoperatively and at 24 months postop. The investigators believe that with this imaging, biomarkers will be able to be seen to assist in prediction of long term outcomes in patients with spinal cord compression. These patients will be compared to healthy cohorts who will also undergo an MRI using the DBSI technology.

Conditions

  • Cervical Spondylotic Myelopathy

Interventions

DIAGNOSTIC_TEST

MRI with DBSI technology

The MRI will be done with diffusion basis spectrum imaging

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Wilson Z Ray, MD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-29
Primary Completion
2024-03-30
Completion
2025-12-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03296592 on ClinicalTrials.gov